ESPERION THERAPEUTICS INC/MI
10-Q, EX-27.1, 2000-09-21
PHARMACEUTICAL PREPARATIONS
Previous: ESPERION THERAPEUTICS INC/MI, 10-Q, EX-3.4, 2000-09-21
Next: INFOTOPIA INC, S-8 POS, 2000-09-21



<TABLE> <S> <C>

<PAGE>

<ARTICLE> 5
<CIK> 0001066745
<NAME> ESPERION THERAPEUTICS, INC.
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                          22,685
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                23,084
<PP&E>                                           2,937
<DEPRECIATION>                                    (799)
<TOTAL-ASSETS>                                  25,877
<CURRENT-LIABILITIES>                           (5,370)
<BONDS>                                              0
                                0
                                       (219)
<COMMON>                                            (2)
<OTHER-SE>                                     (18,311)
<TOTAL-LIABILITY-AND-EQUITY>                   (25,877)
<SALES>                                              0
<TOTAL-REVENUES>                                     0
<CGS>                                                0
<TOTAL-COSTS>                                   11,892
<OTHER-EXPENSES>                                  (685)
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                (11,207)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            (11,207)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (11,207)
<EPS-BASIC>                                     (16.28)
<EPS-DILUTED>                                   (16.28)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission